India’s first machine to automate manual processes of molecular diagnostic tests

Mylab Discovery Solutions has launched ‘Compact XL’ – India’s first machine to automate the manual processes of molecular diagnostic tests such as RT-PCR tests for Covid-19.

Daily Current Affairs Quiz 2020

Key-Points

Compact XL is a compact bench-top machine that will automate lab processes from sample handling to preparing RT-PCR ready tubes.

It is a cartridge-based machine and can test multiple samples at the same time. It can be used for a wide range of RNA/DNA-based tests including Covid-19 RT-PCR tests.

The machine can take input of various sample types such as plasma, tissue, sputum and swab.

Compact XL will replace the need of 700 sq ft of clean room lab with a 4×3 benchtop machine and reduce the need of 3-4 expert technicians to just one, saving operational costs for labs.

Mylab Discovery Solutions

Mylab Discovery Solutions Pvt Ltd is an Indian biotechnology company that produces molecular diagnostic detection kits in the field of medical diagnostics, drug discovery, biomedical research and agricultural genomics.

They were the first company in the country to make ID-NAT screening kits for quantitative HIV, Hepatitis B vaccine and Hepatitis C vaccines.

The company by choice does not have any external investor and does not avail of government subsidies.

In March 2020 they developed the first made in India Covid-19 testing kit which has also been commercially approved by the Central Drugs Standard Control Organisation, Drug Controller General of India and Indian Council of Medical Research.